A 35-year-old woman presents to the clinic to discuss her risk for breast cancer. Her mother and maternal aunt were both diagnosed with breast cancer in their early 40s. The patient's mother recently underwent genetic testing and was told she has a pathogenic BRCA1 mutation. The patient is currently asymptomatic but is requesting genetic testing for herself to understand her risk. Arrange the following steps in the most appropriate standard sequence for the clinical genetic evaluation and management of this patient.
- 1Verify the specific pathogenic variant by reviewing the affected mother's official genetic test report.
- 2Conduct comprehensive pre-test genetic counseling to discuss the implications, benefits, and limitations of testing.
- 3Obtain written informed consent and collect a biological specimen for targeted molecular analysis.
- 4Provide post-test counseling to disclose the molecular results and explain their clinical significance.
- 5Develop and implement a personalized cancer screening and risk-reducing management plan.
Cevap
The most appropriate chronological order is: 1) Verify the specific familial mutation, 2) Conduct pre-test genetic counseling, 3) Obtain informed consent and collect the specimen, 4) Provide post-test counseling, and 5) Develop a personalized cancer screening and management plan.
In the context of predictive genetic testing for a known familial mutation (such as BRCA1), the established standard of care follows a specific sequence to ensure clinical accuracy and ethical practice. First, the exact pathogenic variant must be verified from the affected relative's official report to ensure the correct targeted molecular test is ordered. Second, comprehensive pre-test genetic counseling is mandatory to ensure the patient understands the psychosocial, medical, and financial implications. Third, after informed consent is obtained, a biological sample is drawn for the targeted molecular analysis. Fourth, post-test counseling is provided to interpret the results accurately for the patient. Finally, these molecular results are used to formulate a personalized, long-term clinical management and surveillance plan.
Adım Adım Çözüm
Anahtar Kavram
Clinical workflow for predictive genetic testing of familial mutations